we have studied the effects of intravenous infusion of saralasin , a competitive antagonist of angiotensin ii , in 27 hypertensive patients : 13 had essential hypertension , 14 had renal lesions which involved the renal artery in 9 cases .
C0036193
saralasin
C0003009
angiotensin ii